LSD1 is required for MLL-AF9 cells to initiate AML and knockdown or inhibition of LSD1 suppresses the clonogenic and repopulating potential of AML leukemic stem cells (LSCs) [82,83]. Here, KMT2A is linked to acute myeloid leukemia.